Identification by Hybridization Histochemistry of Human Endometrial Cells Expressing mRNAs Encoding a Uterine β-Lactoglobulin Homologue and Insulin-Like Growth Factor-Binding Protein-1
Abstract:A beta-lactoglobulin homologue (beta LG/PP14) and insulin-like growth factor-binding protein-1 (IGFBP-1) are two major secretory proteins of the human endometrium. In the present study, we have shown that beta LG/PP14 mRNA is expressed in the endometrium in a cyclic manner, being hardly detectable in midcycle and most abundant during the late secretory phase. IGFBP-1 mRNA is also expressed in endometrium, but in amounts smaller than those encoding beta LG/PP14 and with maximal accumulation earlier in the secre… Show more
“…IGFBP-4 and IGFBP-5 mRNAs remain unchanged during the menstrual cycle (Rutanen et al 1993). IGFBP-1 mRNA is not detected in proliferative endometrium but is present in the stromal cells of the secretory endometrium ( Julkunen et al 1990, Zhou et al 1994.…”
Section: Regulation Of Proliferation and Differentiation In The Endommentioning
confidence: 92%
“…After ovulation, progesterone is prominent and stimulates the endometrial stromal cells to secrete IGFBP-1, which in turn modulates the bioactivity of IGF-I (Rutanen & Pekonen 1991). In addition, IGFBP-1 mRNA is localized to predecidualized stromal cells in late secretory endometrium and to decidual cells in pregnancy endometrium ( Julkunen et al 1990. The timing and cellular localization of IGFBP-1 in human endometrium suggest that this protein is associated with decidual differentiation of the stromal cells.…”
Section: Regulation Of Proliferation and Differentiation In The Endommentioning
“…IGFBP-4 and IGFBP-5 mRNAs remain unchanged during the menstrual cycle (Rutanen et al 1993). IGFBP-1 mRNA is not detected in proliferative endometrium but is present in the stromal cells of the secretory endometrium ( Julkunen et al 1990, Zhou et al 1994.…”
Section: Regulation Of Proliferation and Differentiation In The Endommentioning
confidence: 92%
“…After ovulation, progesterone is prominent and stimulates the endometrial stromal cells to secrete IGFBP-1, which in turn modulates the bioactivity of IGF-I (Rutanen & Pekonen 1991). In addition, IGFBP-1 mRNA is localized to predecidualized stromal cells in late secretory endometrium and to decidual cells in pregnancy endometrium ( Julkunen et al 1990. The timing and cellular localization of IGFBP-1 in human endometrium suggest that this protein is associated with decidual differentiation of the stromal cells.…”
Section: Regulation Of Proliferation and Differentiation In The Endommentioning
“…Glycodelin is a protein synthesized by secretary / decidualized endometrial glands. Circulating glycodelin may reflect endometrial function such as endometrial maturation and inhibition of endometrial immune response to the embryo (M. Seppala, et al 1988;M. Julkunen, et al 1990; AE.…”
Section: Insulin Resistance / Hyperinsulinemia and Implantation Disordermentioning
“…A retrospective study 15 divided 712 women who became pregnant after receiving donat-inhibiting the immune response of the endometrium to the embryo [25][26][27][28][29] . More specifically, it has been shown to primarily inhibit mixed lymphocyte reaction and natural killer cell activity 27,29 .…”
Section: Obesitymentioning
confidence: 99%
“…Glycodelin (previously known as PP14) and IGF binding protein-1 (IGFBP-1) are two proteins secreted by the endometrium that appear to play important roles in endometrial receptivity during implantation and early pregnancy 24,25 . Glycodelin is a glycoprotein produced by secretory and decidualized endometrial glands during the luteal phase that facilitates implantation by…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.